These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22583128)

  • 1. Design and characterisation of doxorubicin-releasing chitosan microspheres for anti-cancer chemoembolisation.
    Park JM; Lee SY; Lee GH; Chung EY; Chang KM; Kwak BK; Kuh HJ; Lee J
    J Microencapsul; 2012; 29(7):695-705. PubMed ID: 22583128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-sensitive hollow spheres from chitosan-graft-β-cyclodextrin for controlled drug release.
    Yu N; Li G; Gao Y; Liu X; Ma S
    Int J Biol Macromol; 2016 Dec; 93(Pt A):971-977. PubMed ID: 27663551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-triggered chitosan nanogels via an ortho ester-based linkage for efficient chemotherapy.
    Yang G; Wang X; Fu S; Tang R; Wang J
    Acta Biomater; 2017 Sep; 60():232-243. PubMed ID: 28479490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
    Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
    Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells.
    Tao X; Chen H; Sun XJ; Chen JF; Roa WH
    Int J Pharm; 2007 May; 336(2):376-81. PubMed ID: 17223293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2.
    Niu X; Feng Q; Wang M; Guo X; Zheng Q
    J Microencapsul; 2009 Jun; 26(4):297-305. PubMed ID: 18788036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
    Anal AK; Stevens WF; Remuñán-López C
    Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
    Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
    J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.
    Zeng W; Huang J; Hu X; Xiao W; Rong M; Yuan Z; Luo Z
    Int J Pharm; 2011 Dec; 421(2):283-90. PubMed ID: 22001532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis.
    Kunjachan S; Gupta S; Dwivedi AK; Dube A; Chourasia MK
    J Microencapsul; 2011; 28(4):301-10. PubMed ID: 21545321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
    Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells.
    Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S
    Chem Biol Drug Des; 2013 Sep; 82(3):296-306. PubMed ID: 23594157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of ionically crosslinked chitosan-tripolyphosphate microspheres using Plackett-Burman factorial design for the treatment of intrapocket infections.
    Yadav SK; Khan G; Bansal M; Vardhan H; Mishra B
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1801-1816. PubMed ID: 28673095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin loading and eluting characteristics of bioresorbable hydrogel microspheres: in vitro study.
    Weng L; Le HC; Lin J; Golzarian J
    Int J Pharm; 2011 May; 409(1-2):185-93. PubMed ID: 21382461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas.
    Jones AK; Bejugam NK; Nettey H; Addo R; D'Souza MJ
    J Drug Target; 2011 Jul; 19(6):427-33. PubMed ID: 20678033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(sebacic anhydride) nanocapsules as carriers: effects of preparation parameters on properties and release of doxorubicin.
    Bagherifam S; Griffiths GW; Mælandsmo GM; Nyström B; Hasirci V; Hasirci N
    J Microencapsul; 2015; 32(2):166-74. PubMed ID: 25323326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexes.
    Tsai HY; Chiu CC; Lin PC; Chen SH; Huang SJ; Wang LF
    Macromol Biosci; 2011 May; 11(5):680-8. PubMed ID: 21360679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.